Company page

Regenicin Inc

Regenicin Inc (RGIN) is a public company based in the United States, with a market capitalization of approximately $15.35 million. The company focuses on developing regenerative medicine solutions. As a publicly traded entity, it is listed on the American stock market, providing investors with opportunities to engage with its growth and innovations.